Keyphrases
Acute Decompensated Heart Failure
25%
Acute Myocardial Infarction
6%
Aspirin
10%
Biologically Active Substances
5%
Cardiac Ejection Fraction
6%
Cardiac Function
6%
Cardiac Hypertrophy
5%
Cardiac Remodeling
9%
Cardiocyte
7%
Chronic Heart Failure
7%
Clinical Outcomes
6%
Clinical Trials
9%
Confidence Interval
6%
Congestive Heart Failure
9%
Dilated Cardiomyopathy
7%
Disease Progression
7%
Ejection Fraction
5%
Failing Heart
11%
Gene Expression
6%
Hazard Ratio
7%
Heart Failure
80%
Heart Failure Patients
16%
Heart Failure Treatment
5%
Heart Failure with Preserved Ejection Fraction (HFpEF)
21%
Human Heart
6%
Inflammation
9%
Inflammatory Cytokines
8%
Inflammatory Mediators
8%
Innate Immune Response
6%
Interleukin-6
5%
Left Ventricular Assist Device
5%
Left Ventricular Dysfunction
8%
Left Ventricular Ejection Fraction
14%
Left Ventricular Function
14%
Left Ventricular Remodeling
15%
Mammalian Heart
6%
Murine Model
6%
Myocardial Infarction
7%
Myocardium
9%
Myocytes
12%
Overexpression
11%
Patients with Heart Failure
24%
Placebo
5%
Randomized Clinical Trial
5%
Reduced Ejection Fraction
5%
Sinus Rhythm
6%
TNF Receptor 1 (TNFR1)
10%
Tumor Necrosis Factor-α
48%
Ventricular Assist Device
9%
Warfarin
11%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
8%
Acute Heart Failure
8%
Acute Heart Infarction
6%
Clinical Trial
6%
Congestive Cardiomyopathy
5%
Congestive Heart Failure
100%
Cytokine
17%
Disease Exacerbation
6%
Heart Failure with Preserved Ejection Fraction
5%
Heart Failure with Reduced Ejection Fraction
7%
Heart Infarction
8%
Heart Left Ventricle Failure
8%
Heart Muscle Ischemia
5%
Heart Ventricle Hypertrophy
5%
Heart Ventricle Remodeling
15%
Infarction
5%
Inflammation
9%
Placebo
6%
Randomized Clinical Trial
5%
Tumor Necrosis Factor
34%
Tumor Necrosis Factor Receptor
5%
Warfarin
9%
Medicine and Dentistry
Assisted Circulation
9%
Cardiac Muscle Cell
8%
Cardiovascular System
8%
Clinical Trial
8%
Combination Therapy
5%
Congestive Heart Failure
89%
Cytokine
11%
Dilated Cardiomyopathy
5%
Ejection Fraction
10%
Gene Expression
5%
Heart Failure with Preserved Ejection Fraction
7%
Heart Failure with Reduced Ejection Fraction
6%
Heart Left Ventricle Ejection Fraction
9%
Heart Left Ventricle Failure
6%
Heart Ventricle Remodeling
12%
Hemodynamic
6%
Inflammatory Mediator
5%
Left Ventricular Assist Device
6%
Myocardium
6%
Quality of Life
5%
Systolic Heart Failure
5%
Tumor Necrosis Factor
27%
Ventricular Assist Device
8%
